Home » Stocks » MBOT

Microbot Medical Inc. (MBOT)

Stock Price: $7.03 USD 0.08 (1.15%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 49.97M
Revenue (ttm) n/a
Net Income (ttm) -9.17M
Shares Out 7.12M
EPS (ttm) -1.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $7.03
Previous Close $6.95
Change ($) 0.08
Change (%) 1.15%
Day's Open 7.00
Day's Range 6.94 - 7.29
Day's Volume 97,737
52-Week Range 6.03 - 12.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Scientific Advisory Board Expanded with Additions of Global Medical Pioneers and Distinguished Thought Leaders Scientific Advisory Board Expanded with Additions of Global Medical Pioneers and Distinguis...

3 months ago - GlobeNewsWire

Results Validate Findings of Initial Study; End Points Achieved with No Intraoperative Adverse Events

3 months ago - GlobeNewsWire

HINGHAM, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that Harel Gadot, CEO, President and Chief Executive Officer, will be presenting virtually at two upcomi...

4 months ago - GlobeNewsWire

HINGHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company's continued exe...

5 months ago - GlobeNewsWire

Webcast to be Held on Thursday November 12 th at 2:00pm ET

5 months ago - GlobeNewsWire

HINGHAM, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent ap...

7 months ago - GlobeNewsWire

Webinar to be Held on Wednesday August 26th at 11am ET Webinar to be Held on Wednesday August 26th at 11am ET

8 months ago - GlobeNewsWire

World’s First Fully Disposable Surgical Robot Achieved all Endpoints with No Intraoperative Adverse Events

8 months ago - GlobeNewsWire

Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference

8 months ago - GlobeNewsWire

Vascular Interventions Executive Will Contribute Significantly to the Development and Commercialization of LIBERTY Robotic System Vascular Interventions Executive Will Contribute Significantly to the De...

9 months ago - GlobeNewsWire

Microbot: Miniature Medical Device Company Can Be Successful

10 months ago - Seeking Alpha

Proven Track Record of Numerous M&A and Strategic Collaboration Transactions Proven Track Record of Numerous M&A and Strategic Collaboration Transactions

1 year ago - GlobeNewsWire

HINGHAM, Mass., March 03, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Microbot Medical Inc. (NASDAQ: MBOT), please note that in the first paragraph the appoin...

1 year ago - GlobeNewsWire

HINGHAM, Mass., March 03, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), announced the appointment of Eyal Morag, M.D., a leading radiologist, to Chief Medical Officer, effective immed...

1 year ago - GlobeNewsWire

As of late, it has definitely been a great time to be an investor Microbot Medical.

1 year ago - Zacks Investment Research

Multibagger stocks can make most of the bull run, courtesy of strong fundamentals and businesses that can multiply in a short span of time.

Other stocks mentioned: AGRX, AIRI, DERM, SAVA
1 year ago - Zacks Investment Research

HINGHAM, Mass., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has received an official communication from the European Patent Office (EPO) regarding its intention to grant Eur...

1 year ago - GlobeNewsWire

HINGHAM, Mass., Dec. 31, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ) closed its previously announced registered direct offering of 900,901 shares of its common stock at a purchase...

1 year ago - GlobeNewsWire

HINGHAM, Mass., Dec. 30, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical te...

1 year ago - GlobeNewsWire

Microbot Medical Inc. shares slid 24% Friday, after the medical device company announced a $10 million registered direct offering priced at-the-market at $10.50, a discount to its closing price Thursda...

1 year ago - Market Watch

HINGHAM, Mass., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical te...

1 year ago - GlobeNewsWire

HINGHAM, Mass., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT) closed its previously announced registered direct offering of 912,858 shares of its common stock at a purchase pri...

1 year ago - GlobeNewsWire

HINGHAM, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical te...

1 year ago - GlobeNewsWire

Microbot Medical Inc. (NASDAQ: MBOT) shares made a massive gain on Tuesday after the company revealed its Liberty system, which would be the world’s first fully disposable robotic system for use in neur...

1 year ago - 24/7 Wall Street

HINGHAM, Mass., Dec. 23, 2019 (GLOBE NEWSWIRE) --  Microbot Medical Inc. (NASDAQ: MBOT) today announced the revealing of LIBERTYTM, the world’s first fully disposable robotic system for use in neurova...

1 year ago - GlobeNewsWire

HINGHAM, Mass., Oct. 30, 2019 (GLOBE NEWSWIRE) -- In an expansion of its significant global patent estate, Microbot Medical Inc. (Nasdaq: MBOT) announced that the U.S. Patent and Trademark Office (USP...

1 year ago - GlobeNewsWire

Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS TM )

1 year ago - GlobeNewsWire

HINGHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- At the upcoming Rodman & Renshaw Global Investment Conference, Harel Gadot, CEO, President and Chairman of Microbot Medical Inc. (Nasdaq: MBOT), will...

1 year ago - GlobeNewsWire

About MBOT

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a... [Read more...]

Industry
Medical Instruments & Supplies
Founded
2010
CEO
Harel Gadot
Employees
14
Stock Exchange
NASDAQ
Ticker Symbol
MBOT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for MBOT stock is "Buy" and the 12-month stock price forecast is 20.00.

Price Target
$20.00
Analyst Consensus: Buy